Evidence map›Paper›PMID 42020809›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Utility of PSMA PET/CT for staging of favourable risk intermediate risk prostate cancer.

Ming Hei Fu, Han Li, Anne Hong, Miao Wang, Kim Taubman, Tom Sutherland, Damien Bolton, Kapil Sethi, Ming Liu, Lih Ming Wong

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ming Hei FuDepartment of Urology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
Han LiDepartment of Urology, Beijing Hospital, National Center for Gerontology; National Clinical Research Center for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China.
Anne HongDepartment of Urology, Austin Health, Heidelberg, VIC, Australia.
Miao WangDepartment of Urology, Beijing Hospital, National Center for Gerontology; National Clinical Research Center for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China.
Kim TaubmanDepartment of Radiology, St Vincent's Hospital Melbourne, Victoria, Australia.
Tom SutherlandDepartment of Radiology, St Vincent's Hospital Melbourne, Victoria, Australia.
Damien BoltonDepartment of Urology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
Kapil SethiDepartment of Urology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
Ming LiuDepartment of Urology, Beijing Hospital, National Center for Gerontology; National Clinical Research Center for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China. liumingbjh@126.com.ORCID http://orcid.org/0000-0002-4770-4449
Lih Ming WongDepartment of Urology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia. Lih-Ming.Wong@unimelb.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gleason grade group 2Metastatic diseaseNumber needed to scanProstate cancerProstate-specific membrane antigen positron emission tomography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.